Research · Education · Network

We research what science won't let rest.

The healthcare channel brings together the knowledge of a worldwide network of scientists, physicians, therapists and laboratories — and makes it accessible to those affected and to healthcare professionals alike.

Start the course seriesFind a therapist
Mission

A platform for everyone confronted with Long Covid, post-vac syndrome and spike protein-related issues.

We make the knowledge of a growing, interdisciplinary network accessible — research articles, an online course series and a therapist finder. The platform is being expanded step by step.

24
Researchers
10
Countries
200+
Articles
Courses & training

In-depth courses and training — from the fundamentals to specialised topics.

Live webinars with recordings, multi-part course series and professional training for professionals and anyone interested. You'll receive the introductory webinar after registering for free.

Course series · Spikeopathy

Understanding spikeopathy – the course series with Florian Schilling

Five modules (I–V) that build on each other – from the basics to in-depth practice. Thorough, practical and created exclusively for our community.

  • Live sessions on Sundays – around 3 hours each with Florian Schilling.
  • Every session is recorded, so you can also learn at your own pace.
  • A free introduction to get a taste before you decide.
iRufus · Evidence library

Ask the science — sourced answers from the literature.

iRufus searches over 200,000 studies on Long Covid and the spike protein and answers with citations — AI-assisted, verifiable, no diagnosis.

Become a member
About us

A worldwide network — built over years of continuous work.

In late 2019 we began to sense that something bigger was coming. Since then we have been researching, investigating and connecting — with scientists at universities, physicians, laboratories and everyone willing to share their knowledge.

Research project · Spike Challenge

How many people carry spike protein in their blood?

One of the first real-world surveys of circulating S1 spike protein — anonymous, from medical practices. Basis: 693 evaluable tests from 719 participants (as of July 2026).

  • Age is the clearest factor: only 37.8% of 20–29-year-olds test positive; from age 40 roughly two thirds.
  • Stable over six months — the positivity rate stayed consistently high (≈ 59–70%).
Go to the Spike Challenge
66.4%
of tests positive for S1 spike protein
460
positive
233
negative
26
invalid

Exploratory survey · selected cohort · not representative of the general population.